Polyrizon Ltd
polyrizon-biotech.comWhat Do They Do?
Develops nasal-spray hydrogel medical devices intended to form barriers against viruses and allergens, and nasal hydrogel systems designed to deliver medicines inside the nose.
20-F for FY2025, filed Mar 25, 2026
How Do They Make Money?
No revenue reported yet.
20-F for FY2025, filed Mar 25, 2026
Who Do They Compete With?
Competes with Sanofi, GlaxoSmithKline, Merck Sharp Dohme, McNeil Consumer Healthcare, Sunovion Pharmaceuticals, Teva Branded Pharm, Ivax Pharmaceuticals, AstraZeneca, UCB Biopharma, Hikma Pharmaceuticals, Emergent BioSolutions, Pfizer, Teva Pharmaceutical Industries, Opiant Pharmaceuticals, Nasus Pharma, Amphastar Pharmaceuticals, Indivior, Samarth Pharma, Troikaa Pharmaceuticals, and Neon Laboratories
20-F for FY2025, filed Mar 25, 2026Some of the dominant players in the global INCS market include Sanofi, GlaxoSmithKline plc. Merck Sharp Dohme, McNeil Consumer Healthcare…View ↗
Loading...
